Cosmetic Courses held an informative open evening for prospective aesthetic practitioners at its new training facility in London on February 6.
An Enforcement Notice on January 31 highlighting the rules and concerns around botulinum toxin advertising and other prescription-only medicines on social media has prompted a surge of enquiries to the Advertising Standards Authority (ASA).
New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
In December, global pharmaceutical company Allergan celebrated the beginning of the 30th anniversary celebration for Botox with the ringing of the New York Stock Exchange opening bell.
Medical aesthetic practitioners have raised safety and regulation concerns after ex-Love Island star and personal trainer Rykard Jenkins posted images on Instagram of himself training to administer botulinum toxin.
The Advertising Standards Authority (ASA) has banned an Instagram post by Faces by AKJ Aesthetics promoting a dermal filler competition.
The Advertising Standards Authority (ASA) has banned an Instagram post by Beauty Boutique Aesthetics after a complaint regarding misleading advertising and the advertisement of a prescription-only medicine.
Medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota).
The Aesthetic Medicine Congress (TAMC), in association with the British College of Aesthetic Medicine, will take place in Dubrovnik on October 12 and 13.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation application for Evolus’ botulinum toxin type A formulation.